The round, which included more than a dozen investment firms, should give the startup enough cash to get late-stage data for ...

Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...

This drug may reduce the risk of addiction to pain medications by decreasing reliance on opioids to reduce pain.

Biogen Inc. ( NASDAQ: BIIB) Stifel 2025 Virtual CNS Forum Conference March 18, 2025 10:15 AM ET Great. Good morning, everybody. Happy to be moderating my annual panel where Priya has to listen to me ...

Levicept chief executive Eliot Forster told pharmaphorum that the company plans to move to subcutaneous administration of LEVI-04 in later-stage development, noting that the current formulation is ...

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, provided a business ...

The objective of the current study is to investigate the preventive effect ... Network pharmacology results suggest that voltage-gated sodium channel subtypes (Nav1.1, Nav1.2, and Nav1.6) may be the ...

Additionally, 2.8% of participants reported palpitations as an adverse ... Similarly, inhibition of the late Nav1.5 current could help prevent cellular calcium overload and early afterdepolarizations, ...